middle.news
Imricor Accelerates MRI-Guided Cardiac Ablations with FDA Success and 840% Revenue Jump
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Imricor Accelerates MRI-Guided Cardiac Ablations with FDA Success and 840% Revenue Jump
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Successful completion of first FDA module review ahead of expectations
CE Mark submissions for NorthStar platform and in-house catheter manufacturing
Consumables revenue surged over 840% compared to Q4 2023
First MRI-guided cardiac ablation performed in Switzerland
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imricor Medical Systems (ASX:IMR)
OPEN ARTICLE